M.E. ZHELEZOVA¹, B.K. BEKTUR², R.I. SHARIPOVA²

 ¹Institute of Fundamental Medicine and Biology of Kazan Federal University, Kazan

²Department of the medico-sanitary unit of the Kazan Federal University, Kazan

 Contact details:

Zhelezova M.E. — MD, Professor of the Department of Surgery, Obstetrics and Gynecology

Address: 74 Karl Marks St., Russian Federation, Kazan, 420012, tel.: +7 (843) 236-34-51, e-mail:[email protected]

 The purpose — to conduct a systematic analysis of the modern Russian and foreign publications on the role of microbiome in preeclampsia pathogenesis.

Material and methods. Analysis of the modern Russian and foreign publications over the past eight years on the PubMed platform, systematic reviews of Cochrane, MEDLINE, and Google Scholar was conducted.

Results. Preeclampsia is a severe manifestation of placental dysfunction resulting from angiogenic imbalance and inflammation. For a long time, the «sterile uterus» paradigm rejected the possible role of bacteria in the pathogenesis of preeclampsia and other complications of pregnancy. The introduction of new molecular genetics diagnostic methods made it possible to confirm the presence of bacterial communities in the uterus, placenta and amniotic fluid. The physiological microbiome maintains gravidar homeostasis, but dysbiosis in various niches is a potential cause of inflammation and can lead to pathological pregnancy outcomes such as preterm labor and preeclampsia.

Conclusion. The microbiome of the oral cavity, intestines, vagina, uterus and placenta may play a certain role in the preeclampsia pathogenesis.

Key words: pregnancy, placental microbiome, gut microbiome, oral microbiome, preeclampsia, perinatal outcomes.

REFERENCES

1. Pun L.K., Shennan A., Khayett Dzh.A. et al. The International Federation of Gynecology and Obstetrics (FIGO) Preeclampsia Initiative: A Practical Guide to First Trimester Screening and Disease Prevention (adapted version in Russian). Akusherstvo i ginekologiya: novosti mneniya, obuchenie, 2019, vol. 7, no. 4, pp. 32–60 (in Russ.).
2. Timokhina E.V., Strizhakov A.N., Zafiridi N.V. et al. An innovative approach to predicting and treating preeclampsia — world experience. Akusherstvo i ginekologiya, 2019, no. 5, pp. 5–9 (in Russ.).
3. Céline Méhats, Francisco Miralles et Daniel Vaiman. Nouveaux regards sur la prééclampsie. New perspectives on preeclampsia. Med Sci (Paris), 2017, Dec, vol. 3 (12), pp. 1079–1088.
4. Walker C.K., Krakowiak P., Baker A. et al. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr, 2015, vol. 169 (2), pp. 154–162.
5. Timofeeva L.A., Karavaeva A.L., Zubkov V.V. et al. The role of preeclampsia in pregnancy outcomes: a neonatologist’s view. Akusherstvo i ginekologiya, 2019, no. 4, pp. 73–78 (in Russ.).
6. Li-Juan Lv, Sheng-Hui Li, Shao-Chun Li et al. Early-Onset Preeclampsia is associfted with gut microbial alterations in anterpartum postpartum women. Front Cell infect microbiology, 2019, vol. 9, 224 p.
7. Douglas B. Kell, Louise C. Kenny. A dormant microbial component in the development of preeclampsia. Front Med (Lausanne), 2016, vol. 3, pp. 60.
8. Anne L. Dunlop, Jennifer G. Mulle, Erin P. Ferranti. The maternal microbiome and pregnancy outcomes that impact infant heaith: a review. Adv Neonatal Care, 2015, vol. 15 (6), pp. 377–385.
9. Beckers K. Sones. Maternal microbiome and the hypertensive disorder of pregnancy, preeclampsia. J.L American Journal of Physiology-Heart and Circulatory Physiology, 2019.
10. Ahmadian E., Rahbar Saadat Y., Hosseiniyan Khatibi S.M. et al. Pre-Eclampsia: Microbiota possibly playing a role. Pharmacol Res, 2020, vol. 155, p. 104692.
11. Dunn A.B., Hanson L., Vande Vusse L. et al. Through the microbial looking glass: Premature labor, Preeclampsia and Gestational Diabetes: a scoping review. J Perinat Neonat Nurs, 2019, vol. 33 (1), pp. 35–51.
12. Aagaard K., Ma J., Antony K.M. et al. The placenta harbors a unique microbiome. Sci Transl Med, 2014, vol. 6 (237), p. 237ra65.
13. Gomez-arango L.F., Barett H.L., Mclntyre H.D. et al. Contributios of the maternal oral and gut microbiome to placental microbial colonization in overweight and obese pregnant women. Sci Rep, 2017, vol. 7 (1), p. 2860.
14. Perez-Muñoz M.E., Arrieta M.C., Ramer-Tait A.E. et al. A critical assessment of the «sterile womb» and «in utero colonization» hypotheses: implications for research on the pionner infant mcrobiome. Microbiome, 2017, vol. 5 (1), p. 48.
15. Amarasekara R., Jayasekara R.W., Senanayake H. et al. Microbiome of the placenta in pre-eclampsia supports the role ob bacteria in the multifactorial cause of pre-eclampsia. J Obset Gynaecol Res, 2015, vol. 41 (5), pp. 662–669.
16. Park S.R., Kim D.J., Han S.H. et al Diverse Toll-like receptors mediate cttokine production by Fusobakterium nucleatum and Aggrregatibacter actinomycetemcomitans in macrophage. Infect Immun, 2014, vol. 85 (5), pp. 1914–1920.
17. Ganesh B.P., Klopfleisch R., Loh G. et al. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infeted gnotobiotic mice. PLoS One, 2013, vol. 8 (9), p. e74963.
18. Barak S., Oettinger-Barak O., Machtei E.E. et al. Evidene of peripathogenic microorganisms in placentas of women with preeclampsia. J Peridontol, 2007, vol. 78 (4), pp. 670–676.
19. Swati P., Ambika Devi K., Thomas B. et al. Simultaneous detection of periodontal pathogens in subgingival plaque and placenta of women with hypertension in pregnancy. Arch Gynecol Obstet, 2012, vol. 285 (3), pp. 613–619.
20. Benner M., Ferwerda G., Joosten I. et al. How uterine microbiota might be responsible for a recepive, fertile endometrium. Hum reprod Update, 2018, vol. 24 (4), pp. 393–415.
21. Franasiak J.M., Werner M.D., Juneau C.R. et al. Endometrial microbiome at the time of embryo transfer: next-generation sequencing of the 16 S ribosomal subunit. J Assist Reprod Genet, 2016, vol. 33, pp. 129–136.
22. Moreno I., Codoner F.M., Vilella F. et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol, 2016, vol. 215, pp. 684–703.
23. Molina N.M., Sola-Leyva A., Saez-Lara M.J. et al. New opportunities for endometrial health by modifying uterine microbial composition: present or future? Biomolecules, 2020, vol. 10 (4), pp. 593.
24. Walther-Antonio M.R., Chen J., Multinu F. et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med, 2016, vol. 8, p. 122.
25. Buffie C.G., Pamer E.G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol, 2013, vol. 13, pp. 790–801.
26. Spurbeck R.R., Arvidson C.G. Inhibibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobabacillus species. Infect Immun, 2008, vol.76 (7), pp. 3124–3130.
27. Moffett A., Hiby S.E., Sharkey A.M. The role of the maternal immune system in the regulation of human birthweight. Philos Trans R Soc Lond B Biol Sci, 2015, vol. 70, pp. 20140071.